REQUEST A DEMO
Total
USD $0.00
Search more companies

Zymes Bioscience Private Limited (India)

Main Activities: Wholesale Electronic Markets and Agents and Brokers
Full name: Zymes Bioscience Private Limited Profile Updated: January 13, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English Download a sample report

Zymes Bioscience Private Limited is an unlisted company, incorporated on 09/04/2012. It has its registered office in the State of Delhi, India. Company's corporate identification number (CIN) is U51102DL2012PTC234105 and registration number is 234105. The company is a manufacturing company, it is engaged in chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.

Legal Address
Office No. 1 ,2Nd Floor, B-20 Okhla Industrial Area Ph-2
South Delhi; Delhi; Postal Code: 110020

Contact Details: Purchase the Zymes Bioscience Private Limited report to view the information.

Basic Information
Total Employees:
Purchase the Zymes Bioscience Private Limited report to view the information.
Registered Capital:
Purchase the Zymes Bioscience Private Limited report to view the information.
Financial Auditors:
Purchase the Zymes Bioscience Private Limited report to view the information.
Incorporation Date:
April 09, 2012
Key Executives
Purchase this report to view the information.
Promoter Director
Purchase this report to view the information.
Promoter Director
Ownership Details
Purchase this report to view the information.
33.33%
Company Performance
Financial values in the chart are available after Zymes Bioscience Private Limited report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency INR. Absolute financial data is included in the purchased report.
Net sales revenue
-9.77%
Total operating revenue
-9.75%
Operating profit (EBIT)
-29.37%
EBITDA
-28.32%
Net Profit (Loss) for the Period
-7.19%
Total Assets
22.9%
Total Equity
31.93%
Operating Profit Margin (ROS)
-1.23%
Net Profit Margin
0.11%
Return on Equity (ROE)
-12.3%
Debt/Equity
4.15%
Quick Ratio
0.1%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?